Results 201 to 210 of about 31,793 (243)

Antiplatelet therapy trends in Chinese ischemic stroke patients 2019-2024. [PDF]

Sci Rep
Wu M, Jiang H, Sun A, Zhu B, Zhao Z.
europepmc   +1 more source

VALIDATION OF HPLC METHOD FOR COMPARATIVE STABILITY DETERMINATION IN STUDYING THE DELIVERY OF THE DRUG TICAGRELOR VIA NASOGASTRIC TUBE (in vitro)

А. V. Yegorova, Yu. V. Skrypynets, I. I. Chebotarska, D. I. Aleksandrova, N. M. Sukhostavska, G Kiriiak, S. N. Kashutskyy   +6 more
openalex   +2 more sources

Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How. [PDF]

J Clin Med
Martini L, Lisi M, Pompei G, Arioti M, Bendandi F, Henein MY, Cameli M, Rubboli A.   +7 more
europepmc   +1 more source

The risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel: systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Alamzaib SM, Maniya MT, Hazaveh S, Cheema AAA, Sultan W, Qatanani A, Mirza MO, Damito S, Kumar M, Hassan SA, Khan TJ.   +10 more
europepmc   +1 more source

Intensive antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction. [PDF]

Sci Rep
Matejka J, Motovska Z, Hlinomaz O, Kala P, Hromadka M, Varvarovsky I, Dusek J, Jarkovsky J, Rokyta R, Mrozek J, Cervinka P, Simek S, Ostransky J.   +12 more
europepmc   +1 more source

Evaluation of the Effect of Ticagrelor Dose Interruption and Treatment Resumption with or without Bolus Doses Through Population PK/PD Simulation. [PDF]

Eur J Drug Metab Pharmacokinet
Matsui H, Pham LTT, Adane E.
europepmc   +1 more source

Ticagrelor-induced acute isolated thrombocytopenia.

Indian J Pharmacol
Poddar P, Podila A, Momin MAB.
europepmc   +1 more source